TP53BP2 and familial pancreatic carcinoma: We also found that ASPP2 was down-regulated in the pancreatic cancer tissues compared with para-pancreatic cancer tissues, suggesting that decrease of ASPP2 leading to upregulated autophagy might serve as a chemotherapy intrinsic defense mechanism for pancreatic cancer cells.